Ontology highlight
ABSTRACT:
SUBMITTER: Stojsavljevic-Shapeski S
PROVIDER: S-EPMC7868699 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
Journal of clinical and translational hepatology 20201127 1
Patients with nonalcoholic steatohepatitis (NASH) are at higher risk of progression to advanced stages of fibrosis, cirrhosis, hepatocellular carcinoma and other end-stage liver disease complications. When addressing treatment of NASH, we have limited approved options, and the mainstay of therapy is lifestyle intervention. Extensive research and revelation in the field of pathogenesis of NASH has offered new possibilities of treatment and emerging new drugs that are being tested currently in num ...[more]